Conclusion
We have described the treatment of children with IH with propranolol only or initial propranolol therapy followed by laser therapy, surgical excision, corticosteroid therapy, or a second cycle of propranolol at a tertiary medical center. The study confirms propranolol’s effectiveness and safety, reinforcing the need for early intervention and close monitoring following treatment termination to prevent regrowth. The results highlight the value of proactively addressing IH in this population and underscore the potential impact of familial history on treatment outcomes. The pursuit of larger prospective, multicenter studies encompassing diverse IH cases is warranted to fortify these findings. Ultimately, this research contributes to advancing the understanding and treatment of IH, aiming to optimize patient outcomes and reduce morbidity.